Pediatric Radiology (2018) 48:451–452 https://doi.org/10.1007/s00247-017-4046-z Published online: 15 February 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2017 MIBG avidity correlates with clinical features, tumor bi- (eRMS) is the most common subtype of RMS accounting ology, and outcomes in neuroblastoma: a report from the for approximately 49% of all RMS. Patients with metastatic Children’s Oncology Group RMS have a poor prognosis apart from children with eRMS DuBois SG, Mody R, Naranjo A et al whose metastases are confined to the lungs. The patients in Pediatr Blood Cancer (2017) 64:e26545 this study were analysed with a focus on response to induction chemotherapy. Response at week 7–10 was based on anatom- The authors compared the clinical and biologic features, ic imaging (chest CT) and determined for pulmonary metas- and clinical outcomes between patients with MIBG non- tases as a complete response with disappearance of all lesions avid and MIBG-avid neuroblastoma. The patient cohorts (pCR) or no complete response (no-pCR). Event-free (EFS) were taken from metastatic high- and intermediate-risk and overall (OS) survival were the endpoints. pCR at week 7– neuroblastoma COG studies. Lower-risk tumors such as 10 and the addition of maintenance therapy were favourable ganglioneuroma and ganglioneuroblastoma have been prognostic
Pediatric Radiology – Springer Journals
Published: Feb 22, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera